Stemness and plasticity of lung cancer cells: paving the road for better therapy

Judong Luo1, Xifa Zhou2, Juan Sebastian Yakisich3

  • 1Changzhou Tumor Hospital, Soochow University, Changzhou, People's Republic of China ; School of Radiation Medicine and Protection, Jiangsu Province Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, People's Republic of China.

Insights

Lung cancer stem cells (CSCs) are not fully understood, hindering effective therapies. Research suggests lung cancer cells are versatile, challenging the classical CSC model and proposing new therapeutic strategies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Stem Cell Research

Background:

  • Lung cancer causes significant mortality, with cancer stem cells (CSCs) offering a potential therapeutic target.
  • The precise nature and role of lung CSCs remain largely unknown, limiting treatment efficacy.
  • Current understanding of CSC properties and tumor biology is insufficient for clinical success.

Purpose of the Study:

  • To review stemness and plasticity properties of lung cancer cells.
  • To evaluate the validity of the classical CSC model in lung cancer.
  • To propose alternative models for understanding lung cancer stemness.

Main Methods:

  • Literature review of experimental evidence from lung cancer cell lines.
  • Analysis of patient-derived primary lung cancer cultures.
  • Comparative analysis of findings with the classical CSC model.

Main Results:

  • Experimental data from lung cancer cell lines and primary cultures do not fully support the classical CSC model.
  • Lung cancer cells exhibit significant versatility and plasticity.
  • The existence of a distinct, classical CSC subpopulation in lung cancer is questionable.

Conclusions:

  • The classical CSC model may not accurately represent lung cancer.
  • Lung cancer cells demonstrate remarkable adaptability, suggesting a more dynamic tumor model.
  • New conceptual models are needed to guide the development of effective lung cancer therapies targeting stemness.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
3.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K